This meta-analysis may finally clarify which patients are most likely to respond to hormonal therapy.

This large-scale study is an important contribution to the literature, notes Dr JoAnn Manson, but should it change practice?

Dr Walton-Shirley reviews the key updates in the 2017 ACC/AHA guidelines for the Prevention, Detection, Evaluation and Management of High Blood Pressure with the guideline chair.

Drug holidays should not be taken when using denosumab; molecular breast imaging may outperform mammography; and other topics, as reviewed during the NAMS annual meeting.

Dr JoAnn Manson comments on a recent study revealing that gestational diabetes is like a window into a woman's future risk for cardiovascular disease and type 2 diabetes.

Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society.

ACOG no longer recommends breast self-exams to average-risk women, but it does recommend breast education and awareness.

Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says.

What is the latest on fish oil supplementation for cardiovascular disease prevention? Dr Manson reviews a new science advisory from the American Heart Association.

Dr Maurie Markman discusses new research on therapy for low-grade serous cancer of the ovary from the Journal of Clinical Oncology.